Oncogenic KRAS signalling in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is almost universally fatal. The annual number of deaths equals the number of newly diagnosed cases, despite maximal treatment. The overall 5-year survival rate of <5% has remained stubbornly unchanged over the last 30 years, despite tremendous efforts in p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Eser, S, Schnieke, A, Schneider, G, Saur, D
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2014
Konular:
Minireview
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150259/
https://ncbi.nlm.nih.gov/pubmed/24755884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.215
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller